Senti Biosciences is trading at $0.38, up +6.49%, alongside broader market strength.
- The Nasdaq Composite is up 0.72%, with investors focused on the July CPI report.
- Searches found no new company-specific announcement dated August 12, 2026.
- The latest major company news remains the May 14 FDA RMAT update, making broader market sentiment the most likely explanation.